FASLG and graft versus host disease: This finding points to the protective effect that NK cells have in cGvHD pathophysiology; it was demonstrated (42) that NK cells mediate the reduction of GvHD by inhibiting activated, alloreactive T cells while retaining graft-versus-tumor effects through effector molecules such as FasL (43).